DK1287832T3 - Anvendelse af antagonist af leukæmiinhiberende faktor - Google Patents

Anvendelse af antagonist af leukæmiinhiberende faktor

Info

Publication number
DK1287832T3
DK1287832T3 DK02016730T DK02016730T DK1287832T3 DK 1287832 T3 DK1287832 T3 DK 1287832T3 DK 02016730 T DK02016730 T DK 02016730T DK 02016730 T DK02016730 T DK 02016730T DK 1287832 T3 DK1287832 T3 DK 1287832T3
Authority
DK
Denmark
Prior art keywords
antagonist
inhibitory factor
leukemia inhibitory
administered
treatment
Prior art date
Application number
DK02016730T
Other languages
English (en)
Inventor
Elizabeth A Luis
Napoleone Ferrara
Kathleen King
Jennie P Mather
Nicholas F Paoni
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of DK1287832T3 publication Critical patent/DK1287832T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK02016730T 1995-04-24 1996-04-17 Anvendelse af antagonist af leukæmiinhiberende faktor DK1287832T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42738395A 1995-04-24 1995-04-24
EP96913814A EP0830143B1 (en) 1995-04-24 1996-04-17 Use of leukemia inhibitory factor and endothelin antagonists

Publications (1)

Publication Number Publication Date
DK1287832T3 true DK1287832T3 (da) 2006-05-01

Family

ID=23694642

Family Applications (2)

Application Number Title Priority Date Filing Date
DK96913814T DK0830143T3 (da) 1995-04-24 1996-04-17 Anvendelse af leukæmiinhiberende faktor og endothelinantagonister
DK02016730T DK1287832T3 (da) 1995-04-24 1996-04-17 Anvendelse af antagonist af leukæmiinhiberende faktor

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK96913814T DK0830143T3 (da) 1995-04-24 1996-04-17 Anvendelse af leukæmiinhiberende faktor og endothelinantagonister

Country Status (12)

Country Link
EP (2) EP1287832B1 (da)
JP (1) JPH11504332A (da)
AT (2) ATE233570T1 (da)
AU (1) AU702375B2 (da)
CA (1) CA2214636C (da)
DE (2) DE69635630T2 (da)
DK (2) DK0830143T3 (da)
ES (1) ES2254564T3 (da)
IL (1) IL117998A (da)
MX (1) MX9707939A (da)
WO (1) WO1996033740A1 (da)
ZA (1) ZA963274B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000001404A1 (en) 1998-07-06 2000-01-13 The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services Compositions and methods for $i(in vitro) fertilization
EP1549198A4 (en) * 2002-09-30 2007-03-28 Univ Duke THYMUSATROPHI
JP2011231014A (ja) * 2008-08-27 2011-11-17 Keiichi Fukuda 心不全の治療剤
EP2371860A1 (en) * 2010-04-05 2011-10-05 Fundació Privada Institut d'Investigació Oncològica de Vall d'Hebron Antibody recognising human leukemia inhibitory factor (LIF) and use of anti-LIF antibodies in the treatment of diseases associated with unwanted cell proliferation
SI3555132T1 (sl) 2016-12-19 2024-04-30 Medimmune Limited Protitelesa proti LIF in njihove uporabe
US10583191B2 (en) 2016-12-19 2020-03-10 Mosaic Biomedicals Slu Antibodies against LIF and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4231393A (en) * 1992-05-08 1993-12-13 Genentech Inc. Antibodies to leukemia inhibitory factor
WO1995008550A1 (en) * 1993-09-24 1995-03-30 Abbott Laboratories Endothelin antagonists

Also Published As

Publication number Publication date
AU702375B2 (en) 1999-02-18
CA2214636C (en) 2009-12-22
EP1287832A3 (en) 2003-04-16
EP0830143B1 (en) 2003-03-05
EP0830143A1 (en) 1998-03-25
DE69626510D1 (de) 2003-04-10
ZA963274B (en) 1997-10-24
WO1996033740A1 (en) 1996-10-31
MX9707939A (es) 1997-12-31
JPH11504332A (ja) 1999-04-20
DE69635630D1 (de) 2006-01-26
ATE233570T1 (de) 2003-03-15
DE69635630T2 (de) 2006-08-10
DK0830143T3 (da) 2003-06-16
EP1287832A2 (en) 2003-03-05
CA2214636A1 (en) 1996-10-31
IL117998A0 (en) 1996-08-04
ES2254564T3 (es) 2006-06-16
IL117998A (en) 2001-04-30
EP1287832B1 (en) 2005-12-21
ATE313333T1 (de) 2006-01-15
DE69626510T2 (de) 2003-12-11
AU5665896A (en) 1996-11-18

Similar Documents

Publication Publication Date Title
DK0574457T3 (da) Antiviral nucleosidkombination
DE59104440D1 (de) Epiduralkanüle.
DE69206378D1 (de) Patientenliegetische.
DE3879760D1 (de) Gegen abblaetterung wiederstandsfaehige ueberzugsmittel.
DE68920545D1 (de) Polyolefinlaminat mit hoher Festigkeit und hohem Elastizitätsmodul, das verbesserte Festkörper-Tiefziehfähigkeit aufweist.
DE68910799D1 (de) Faserbehandlungszusammensetzung.
FI875544A7 (fi) 3'-deoksitymidin-2'-eenin (3'-deoksi-2',3'-didehydrotymidiini) käyttö retroviruksilla infektoituneiden potilaiden hoitoon.
FI874166A7 (fi) 2',3'-dideoksisytidin-2'-eenin käyttö retroviruksilla infektoituneiden potilaiden hoitoon.
DK0830143T3 (da) Anvendelse af leukæmiinhiberende faktor og endothelinantagonister
DK578887A (da) Antihypertensiva
ATE154507T1 (de) Dentalwerkstoffe auf basis von (meth)-acrylaten
DK0862454T3 (da) CTLA-8 i kombination med G-CSF eller med G-CSF og IL-6 og anvendelse af CTLA-8 til behandling af infektioner
IT8519042A0 (it) Impiego di chinoloni nel trattamento di malattie cardiache.!
FI952018A0 (fi) BHAP-yhdisteiden käyttö yhdessä muiden ei-nukleosidi-käänteistransskriptaasi-inhibiittoreiden kanssa HIV-infektion hoitoon
IT233634Y1 (it) Tavoletta filtro per cannule di gruppi di aspirazione dentistici.
FR2670116B1 (fr) Electrode, notamment electrode temporaire pour le cóoeur.
CO5170411A1 (es) Terapia para la leucemia mielocitica cronica
ES1016025Y (es) Mesa de billar perfeccionada.
ES1019711Y (es) hito de arista perfeccionado.
ES1008159Y (es) Mesa de billar perfeccionada.
FI914878A7 (fi) Hydroxylerade inhibitorer foer hiv:s reverserade transkriptas.
ES1016330Y (es) Mesa de billar.
ES504489A0 (es) Perfeccionamientos introducidos en el objeto de la patente principal num.476.398 por mejoras introducidas en los mandosde volumen de los sistemas de distribucion de sonido
DK0833638T3 (da) Anvendelse af imidazo[1,5-a]quinoloner som neuroprotektive midler
ES1024890Y (es) Plantilla terapeutica perfeccionada.